🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Having fun on the stage with the Italian crew after the amazing plenary talks. This is #ASH22! SIE_Ematologia

Focusin on Fitness in Acute Myeloid Leukemia at the ASH2022 meeting #ASH22 #FitnessAML

We cannot assume that all therapy-related myeloid neoplasms have poor outcomes. Genetics matters! Excited to see this work led by Jad Othman finally out. Grateful for the chance to participate in this important study. #leusm

Selecting the right treatment for the right patient. The crucial role of specific aspects of Fitness for treatment selection in Acute Mueloid Leukemia #FitnessAML #AcuteMyeloidLeukemia haematologica.org/article/view/h…

First step toward harmonized analysis of #AMLMRD Fondazione GIMEMA Haematologica Università di Roma Tor Vergata Policlinico Tor Vergata

Does the opportunity (to treat) comes once in a lifetime? It’s time to consider Fitness a dynamic parameter mdpi.com/2072-6694/15/1… #fitnessAML #acutemyeloidleukemia #leukemia #AML

Incredible opportunity to discuss news from the 2022 ASH meeting in the field of AML (fit and unfit patients). Thank you @JanssenITA for the opportunity! The webinar will be online at hme-forum.com/hme/webinar/50… for 1 month #FitnessAML #AcuteMyeloidLukemia #ASHmeeting2022

Francesco Buccisano tells about From MRD monitoring to MRD-driven treatm... youtu.be/fN69VIoVgKM via YouTube

Honoured to present the 6y update of the GIMEMA AML1310 trial at the ISALXVIII 2023 Meeting in Munich Fondazione GIMEMA #Leukemia #AcuteMyeloidLeukemia #AML #MeasurableResidualDisease #MRD

Our own chair Mandy Lauw leading the brainstorming session at the YoungEHA committee meeting. Lots of new ideas and projects to develop🌱 European Hematology Association

Check some of the hottest topic in AML that were discussed during the ISAL2023 in munich #AML #AcuteMyeloieukemia #FitnessAML #MRD ——————> vjhemonc.com/speaker/raffae…

Thank you VJHemOnc for the opportunity! vjhemonc.com/speaker/raffae…

#ISAL2023 | Raffaele Palmieri discusses the importance of assessing patient fitness when selecting treatment approaches in AML: 🎥 ow.ly/buGM50NuzAo #LeuSM #AMLsm #HemOnc

Discussing news from the European Hematology Association 2023 meeting at the HME forum organized by Janssen Oncolgy Link——-> hme-forum.com/hme/webinar/54…

Next EHA in Milan. See you there….maybe #EHA2024

Hey European Hematology Association, feel free to invite us at next EHA meeting in Milan! Lorenzo Brunetti